Se espera que el mercado de patología anatómica crezca de 22.800,20 millones de dólares en 2022 a 33.145,78 dólares millones para 2028; se estima que crecerá a una tasa compuesta anual del 6,4 % entre 2022 y 2028.
La patología anatómica es una parte importante del estudio y tratamiento de las enfermedades. Es un campo amplio que incluye patología del difunto, patología quirúrgica, citopatología, neuropatología y patología oftálmica. Suele realizarse en laboratorios médicos de hospitales y laboratorios de diagnóstico. El crecimiento del mercado se atribuye a la creciente prevalencia del cáncer y otras enfermedades y a la creciente atención a los medicamentos personalizados. Sin embargo, la falta de profesionales capacitados y las estrictas regulaciones gubernamentales están obstaculizando el crecimiento del mercado.
El mercado de patología anatómica está segmentado en la base del producto y servicio, aplicación, usuario final y geografía. Por geografía, el mercado está ampliamente segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el Sur y el Sur. Centroamérica. El informe ofrece información y un análisis en profundidad del mercado, enfatizando varios parámetros como las tendencias del mercado, los avances tecnológicos, la dinámica del mercado y el panorama competitivo de los principales actores del mercado global.
Perspectivas estratégicas
regiones lucrativas para el mercado de patología anatómica
Perspectivas del mercado
Desarrollo de Nuevas Tecnologías y Lanzamiento de Productos
Existe un enorme margen para la integración de sistemas basados en aprendizaje automático (ML) y inteligencia artificial (IA) en las corrientes médicas, incluyendo patología anatómica. Varios laboratorios de patología anatómica son cada vez más conscientes de los beneficios de la digitalización y la IA en la práctica. Además, los recientes avances tecnológicos y las aprobaciones regulatorias están fomentando la digitalización de los laboratorios. operaciones para mejorar la velocidad y precisión de los procesos. Las herramientas basadas en IA diseñadas adecuadamente tienen un inmenso potencial para mejorar la eficiencia del flujo de trabajo y la precisión del diagnóstico en patología. La tecnología de inteligencia artificial puede mejorar las imágenes de patología, lo que permite una mayor precisión en el diagnóstico y conduce a un tratamiento específico de la enfermedad.
La patología digital, un subcampo en crecimiento dentro de la patología anatómica, utiliza tecnologías digitales para agilizar la recopilación y gestión de datos. Ayuda a reducir los riesgos para las muestras de muestras y tiene el potencial de acelerar la inscripción en ensayos clínicos. Además, puede reducir el tiempo de respuesta entre la muestra y el resultado y agilizar el proceso central de revisión de patología, ofreciendo así oportunidades para aumentar la eficiencia de los ensayos.
En 2018, Sakura Finetek USA, Inc. comercializó Accu-Cut SRM 300 LT, un microtomo. Este microtomo manual con características innovadoras está diseñado para simplificar la visualización de muestras de tejido incluidas en parafina y permitir un corte más seguro. El Accu-Cut SRM 300LT tiene muchas características exclusivas de seguridad para el usuario que reducen el riesgo de lesiones accidentales asociadas con la exposición de la hoja. Varios actores del mercado se centran en introducir soluciones innovadoras. Por ejemplo, RadNet, un proveedor de servicios de imágenes, y Hologic, un desarrollador de productos de diagnóstico, colaboraron para desarrollar herramientas de inteligencia artificial para la salud mamaria. Por lo tanto, es probable que la introducción de nuevas tecnologías y productos surja como una tendencia significativa en el mercado de patología anatómica durante el período de pronóstico.
Información sobre productos y servicios
Basado en productos y servicios, el mercado mundial de patología anatómica se segmenta en instrumentos, consumibles y servicios. El segmento de servicios tuvo la mayor cuota de mercado en 2022; sin embargo, se prevé que el segmento de instrumentos registre la CAGR más alta del 7,0% durante el período de pronóstico.
Application Insights
Según la aplicación, el mercado de patología anatómica se segmenta en diagnóstico de enfermedades, descubrimiento y desarrollo de fármacos, y otros. Es probable que el segmento de diagnóstico de enfermedades tenga la mayor participación del mercado en 2022; sin embargo, se prevé que el segmento de descubrimiento y desarrollo de fármacos registre la CAGR más alta del 7,0% durante el período previsto.
Perspectivas del usuario final
Según el usuario final, el mercado de patología anatómica se segmenta en hospitales, laboratorios de investigación, centros de diagnóstico. laboratorios y otros. El segmento de otros incluye empresas farmacéuticas y de biotecnología y organizaciones de investigación por contrato (CRO). El segmento de hospitales tuvo la mayor participación del mercado en 2022; sin embargo, se prevé que el segmento de laboratorios de diagnóstico registre la CAGR más alta del 7,0% durante el período de pronóstico.
Mercado de patología anatómica, por usuario final: 2022 y 2028
Los lanzamientos de productos y las fusiones y adquisiciones son estrategias muy adoptadas por los actores que operan en el Mercado mundial de patología anatómica. A continuación se enumeran algunos de los desarrollos clave recientes:
- En septiembre de 2021, Roche lanzó el entorno abierto de patología digital para animar a los desarrolladores de software a colaborar para mejorar los resultados de los pacientes y aumentar la atención sanitaria personalizada a través de una imagen novedosa. tecnologías de análisis.
- En mayo de 2021, BioGenex lanzó CD8A, CD56 y CD163, los tres anticuerpos inmunohistoquímicos (IHC) primarios para el diagnóstico del cáncer.
- En agosto de 2021, en EE. UU., BD introdujo un alto nivel completamente automatizado -Sistema de diagnóstico de rendimiento que utiliza robótica y algoritmos de software de gestión de muestras. El sistema creó un punto de referencia en la automatización de pruebas moleculares de enfermedades infecciosas en laboratorios centrales y otros laboratorios centralizados.
- < span>En julio de 2021, BD anunció el lanzamiento comercial del sitio web y de comercio electrónico bdbiosciences.com, un sitio digital completamente "reimaginado". Marketplace para ofrecer a los consumidores y a sus equipos de adquisiciones una mejor experiencia de compra en línea.
La pandemia de COVID-19 y la interrupción que causó en los recursos sanitarios impactaron todos los aspectos de la industria del diagnóstico, incluido el mercado de patología anatómica. El cierre de clínicas, quirófanos y centros médicos. oficinas y el programa "quedarse en casa" Los mandatos en todo el mundo afectaron gravemente la adquisición y envío de muestras para evaluación patológica. En 2020 y 2021, el número de visitas de pacientes a los hospitales se redujo significativamente, a pesar de que los servicios de emergencia y OPD estaban disponibles en los hospitales. Además, la mayoría de los hospitales invirtieron sus esfuerzos y recursos en diagnosticar y tratar la COVID-19; Como resultado, muchas cirugías planificadas fueron canceladas o retrasadas. Por ello, se desactivaron varios sistemas de detección temprana del cáncer y se suspendieron la mayoría de las autopsias. Esta situación dificultó la atención médica de pacientes con enfermedades distintas al COVID-19, incluidos pacientes con enfermedades crónicas, pacientes oncológicos o en espera de trasplante de órganos. En consecuencia, se redujo el número de muestras de patología quirúrgica y citología recibidas en los laboratorios de patología anatómica.
Patología Anatómica - ndash; Segmentación del mercado
Basada en el producto y servicio, la global El mercado de patología anatómica se segmenta en instrumentos, consumibles y servicios. Según la aplicación, el mercado de patología anatómica se segmenta en diagnóstico de enfermedades, descubrimiento y desarrollo de fármacos, y otros. Según el usuario final, el mercado de patología anatómica se segmenta en hospitales, laboratorios de investigación, laboratorios de diagnóstico y otros. Según la geografía, el mercado está segmentado en América del Norte (EE. UU., Canadá y México), Europa (Francia, Alemania, Reino Unido, Italia, España y resto de Europa), Asia Pacífico (China, Japón, India, Australia, Sur Corea y resto de Asia Pacífico), Oriente Medio y Asia. África (Arabia Saudita, Sudáfrica, Emiratos Árabes Unidos y resto de Medio Oriente y África) y Sur y África. Centroamérica (Brasil, Argentina y resto de América Central y del Sur)
Perfiles de empresa
- F. Hoffmann-La Roche Ltd.
- Danaher
- Hologic, Inc.
- Agilent Technologies, Inc.
- BioGenex
- Diapath SpA
- Bio SB< li>Merck KGaA
- BD
- PHC Holdings Corporation
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Anatomic pathology is a field of medicine devoted to studying diseases and disease progression based on the macroscopic, microscopic, biochemical, immunologic, and molecular examination of organs and tissues. It includes tissue specimen evaluations, including cervical scrapings (i.e., PAP smears), biopsies, surgical resections, and whole-body evaluations after autopsy.
Key factors that are driving the growth of this market are increase in prevalence of cancer and other disease, and growing focus on personalized medicines.
The services segment dominated the global anatomic pathology market and held the largest revenue share of 40.04% in 2021.
The disease diagnosis dominated the global anatomic pathology market and held the largest revenue share of 38.46% in 2021.
The hospitals segment dominated the global anatomic pathology market and accounted for the largest revenue share of 48.52% in 2021.
The anatomic pathology market majorly consists of the players such as F. Hoffmann-La Roche AG, Danaher, Hologic, Inc, Agilent Technologies Inc, BioGenex, Diapath S.p.A, Bio SB, Merck KGaA, BD, PHC Holdings Corporation, among others.
Global anatomic pathology market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for anatomic pathology. The US is estimated to hold the largest share in the anatomic pathology market during the forecast period. The growth of the market can be because of rise in cases of chronic diseases such as cancer, and increase in healthcare expenditure in the country. In addition, presence of major market players coupled with large number of funding programs by the public agencies in the region stimulate the growth of anatomic pathology market in North America. On the other hand, enormous number of ongoing developments and innovations in healthcare, and rising spending capabilities in the Asia Pacific is expected to account for the fastest growth of the region during the coming years.
The List of Companies - Anatomic Pathology Market
- F.HOFFMANN-LA- ROCHE Ltd.
- Danaher
- Hologic, Inc.
- Agilent Technologies, Inc.
- BioGenex
- Diapath S.p.A
- Bio SB
- MERCK KGaA
- BD
- PHC Holdings Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)